LGNDNasdaq United States
Market cap
$5.875 B
$293.15 -2.33%
Close of 7 Aug 2026
Revenue
$268.1M
#2192 by revenue
Earnings
$124.5M
#1217 by earnings
Shares outstanding
19,935,609
Latest filing cover page
P/E ratio
47.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Ligand Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.